ASMB
Assembly Biosciences, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Jason A. Okazaki
IPO Date
2010-12-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Assembly Biosciences, Inc.
CEO
Jason A. Okazaki
IPO Date
2010-12-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 6,500 |
| $0.00 |
| 31 Mar 2026 | Bjorkquist Jeanette M | PFO and PAO | S-Sale | Disposed | 312 | $26.65 |
| 31 Mar 2026 | Bjorkquist Jeanette M | PFO and PAO | S-Sale | Disposed | 16 | $27.49 |
| 31 Mar 2026 | White Nicole S | Chief Manufacturing Officer | A-Award | Acquired | 26,000 | $0.00 |
| 31 Mar 2026 | White Nicole S | Chief Manufacturing Officer | S-Sale | Disposed | 188 | $26.65 |
| 31 Mar 2026 | White Nicole S | Chief Manufacturing Officer | S-Sale | Disposed | 9 | $27.49 |
| 31 Mar 2026 | Gaggar Anuj | Chief Medical Officer | A-Award | Acquired | 26,000 | $0.00 |
| 31 Mar 2026 | Delaney William E IV | Chief Scientific Officer | A-Award | Acquired | 26,000 | $0.00 |
| 31 Mar 2026 | Okazaki Jason A | director, officer: CEO and President | A-Award | Acquired | 94,250 | $0.00 |